PlainRecalls
FDA Drug Low Class III Ongoing

Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8

Reported: June 12, 2024 Initiated: May 16, 2024 #D-0543-2024

Product Description

Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8

Reason for Recall

Failed Impurities/Degradation Specifications.

Details

Units Affected
13,440 units
Distribution
Nationwide within the United States
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 13,440 units.
Why was this product recalled?
Failed Impurities/Degradation Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 12, 2024. Severity: Low. Recall number: D-0543-2024.